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Bone Morphogenetic Proteins Promote
Astroglial Lineage Commitment
by Mammalian Subventricular Zone Progenitor Cells
Robert E. Gross,* Mark F. Mehler,* Peter C. Mabie, of an epidermal fate is the result of a positive action of
BMP4.Ziying Zang, Linda Santschi, and John A. Kessler
The BMPs, members of a rapidly expanding subclassDepartments of Neurology, Neurosurgery,
of the transforming growth factor b (TGFb) superfamily,and Neuroscience
participate in a spectrum of cellular inductive eventsand the Rose F. Kennedy Center for Research in Mental
involving all three germ layers during metazoandevelop-Retardation and Human Development
ment (Kingsley, 1994; Massague´ et al., 1994; Mehler andAlbert Einstein College of Medicine
Kessler, 1994; Perides et al., 1992; Wall and Hogan,Bronx, New York 10461
1994; Wang et al., 1993). Their actions are thus not lim-
ited to gastrulation; the BMPs are expressed in multiple
CNS regions throughout development and may regulateSummary
additional early neural cellular processesand participate
in aspects of neuronal maturation (Dewulf et al., 1995;The epigenetic signals that regulate lineage develop-
Fann and Patterson, 1994; Jones et al., 1991; Lein etment in the embryonic mammalian brain are poorly
al., 1995; Liem et al., 1995; Shah et al., 1996; Tomizawaunderstood. Here we demonstrate that a specific sub-
et al., 1995; Zang et al., 1994, Soc. Neurosci., abstract).class of the transforming growth factor b superfamily,
For example, BMP4 and BMP7 mediate a contact-the bone morphogenetic proteins (BMPs), cause the
dependent inductive signal from the ectoderm that dor-selective, dose-dependent elaboration of the astro-
salizes neural floor plate cells and inhibits the ventraliz-glial lineage from murine embryonic subventricular
ing influence of Sonic hedgehog secreted from dorsalzone (SVZ) multipotent progenitor cells. The astroglial
mesoderm (Ericson et al., 1995; Liem et al., 1995). Ininductive effect is characterized byenhanced morpho-
addition, BMP4 has been implicated as a diffusible later-logical complexity and expression of glial fibrillary
alizing signal from lateral plate mesoderm for the specifi-acidic protein, with concurrent suppression of neu-
cation of lateral somites and is opposed by a medializingronal and oligodendroglial cell fates. SVZ progenitor
signal from the neural tube (Pourquie´ et al., 1996). Itcells express transcripts for the appropriate BMP-spe-
thus seems clear that the BMPs mediate both inductivecific type I and II receptor subunits and selective BMP
and suppressive actions, which differentially regulateligands, suggesting the presence of paracrine or auto-
critical fate decisions along multiple developmentalcrine developmental signaling pathways (or both).
axes throughout the period of neural lineage specifica-These observations suggest that the BMPs have a
tion and differentiation.selective role in determining the cell fate of SVZ
There is now compelling evidence that neurons andmultipotent progenitor cells or their more develop-
glia are generated from a common neural precursor cellmentally restricted progeny.
during both CNS and peripheral nervous system devel-
opment (Anderson, 1989, 1995; Cameron and Rakic,Introduction
1991; Davis and Temple, 1994; Kilpatrick and Bartlett,
1993; McConnell, 1991; Reynolds et al., 1992; Reynolds
A range of epigenetic signals are involved in neural fate
and Weiss, 1996; Shah et al., 1996; Stemple and Ander-
potential, lineage specification, and cellular differentia-
son, 1992; Turner and Cepko, 1987; Williams and Price,
tion in the central nervous system (CNS) and peripheral
1995). However, little is known about the genetic and
nervous system (reviewed by Anderson, 1995; Cameron
epigenetic signals that regulate neuronal and glial lin-
and Rakic, 1991; Green, 1994; Patterson and Nawa, eage commitment from developing CNS multipotent and
1993). For example, in Xenopus animal caps undergoing
more restricted neural progenitor cells. In the peripheral
neurogenesis, activin or activin-like molecules, includ-
nervous system, the neuregulins have been shown to
ing bone morphogenetic protein 4 (BMP4), mediate the
regulate the commitment of multipotent precursors de-
suppression of neural fate acquisition by ectoderm rived from the neural crest to a glial cell (Schwann cell)
(Godsave and Slack, 1991; Grunz and Tacke, 1989; Hem- fate, with suppression of neuronal lineage elaboration
mati-Brivanlou and Melton, 1994; Wilson and Hemmati- (Dong et al., 1995; Shah et al., 1994). Recently, two
Brivanlou, 1995). Chordin, noggin, and follistatin, pro- members of the TGFb superfamily, BMP2 and TGFb1,
teins secreted from dorsal mesoderm, induce overlying have been shown to differentially regulate commitment
ectoderm to acquire neural cell fates, possibly by inhib- of neural crest stem cells to neural and smooth muscle
iting the neural suppressive actions of BMP4 or related cell fates, respectively (Shah et al., 1996). Similar factors
molecules (Hemmati-Brivanlou et al., 1994; Holley et al., have not yet been identified that regulate the irreversible
1995; Sasai et al., 1995; Smith and Harland, 1992). In commitment of neural progenitor cells to glial and neu-
addition to its suppressive role in neural fate acquisition, ronal fates in the CNS.
BMP4 is necessary for the induction of epidermal cell The subventricular zone (SVZ) represents a CNS ger-
fates in Xenopus ectoderm (Wilson and Hemmati-Bri- minative zone present during embryonic development
vanlou, 1995). Thus, neural induction represents the de- that contains multipotent neural progenitor cells capa-
repression of a default cell fate, whereas the acquisition ble of generating both neuronal and glial cells under
appropriate environmental conditions (Gates et al.,
1995; Lois and Alvarez-Buylla, 1993; Luskin, 1993; Privat*These authors contributed equally to this work.
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Figure 1. BMPs from Distinct Subclasses of
the TGFb Superfamily Induce Astroglial Lin-
eage Elaboration from EGF-Generated SVZ
Progenitor Cells
Fluorescence photomicrographs of dissoci-
ated SVZ progenitor cells grown on poly-D-
lysine-coated glass coverslips for 7 days in
serum-free media in the absence (A) or pres-
ence of 50 ng/ml BMP2 (B–D) and immuno-
stained with monoclonal antibody directed
against GFAP, followed by rhodamine-conju-
gated anti–mouse IgG secondary antibody.
BMP2 (B) led to a marked increase in astro-
glial cell number, cell size, number of pro-
cesses, and degree of immunoreactivity
when compared with control (A). Cells treated
with TGFb superfamily factors from other
subclasses (TGFb1, activin A, and GDNF) re-
sembled untreated cells on each of these pa-
rameters, whereas effects similar to those
seen after BMP2 applications were observed
with BMP4, BMP5, BMP6, and OP1/BMP7
(see Figure 2). Note that in the presence of
BMP2, astrocytes often attained sizes of 300
mm, three times larger than those observed
in the absence of BMP (C and D). Scale bar
is 95 mm in (A) and (B) and 35 mm in (C) and (D).
and Leblond, 1972). In the presence of epidermal growth as BMP ligands. Taken together, these observations
indicate that the BMPs have a role in determining thefactor (EGF), neural progenitor cells can be selected and
expanded as proliferative neurospheres, which can be commitment of multipotent progenitor cells, or their
more restricted progeny, to the astroglial fate.examined in primary dissociated cultures to define the
complement of progenitor cell species and the regula-
tory signals involved in early CNS developmental events Results
(Reynolds et al., 1992; Reynolds and Weiss, 1992, 1996).
Prior studies have suggested that several general BMPs Induce the Elaboration and Differentiation
of the Astroglial Lineage from EGF-Generatedclasses of growth factors, cytokines, and neurotrophic
factors can influence lineage commitment, cellular dif- SVZ Progenitor Cells
To ascertain whether the BMPs influence lineage elabo-ferentiation, and survival of CNS neural progenitor cells
(Ahmed et al., 1995; Cattaneo and McKay, 1990; Gage ration of multipotent neural progenitor cells, we initially
cultured EGF-generated neural progenitor cells derivedet al., 1995; Mehler et al., 1993, 1995; Murphy et al.,
1990; Vescovi et al., 1993). In view of the developmental from murine embryonic day 17 (E17) striatum in defined
media to generate proliferative neurospheres. The seri-effects of TGFb superfamily factors, including theBMPs,
on early neural fate decisions, we evaluated the actions ally passaged neurospheres were composed of early
neuroepithelial precursors, as demonstrated by theof these factors on glial/neuronal lineage elaboration
from EGF-generated SVZ progenitor cells. We demon- presence of uniform immunoreactivity for the type VI
intermediate filament protein, nestin (Lendahl et al.,strate that various BMPs, but not factors from other
TGFb subclasses (e.g., activin, TGFb1, and glial cell 1990), but did not express markers for early differenti-
ated progeny (O4, oligodendroblasts; the 66 kDa form ofline–derived neurotrophic factor [GDNF]), induce the se-
lective, irreversible elaboration and cellular maturation neurofilament [NF66], neuroblasts; glial fibrillary acidic
protein [GFAP], astrocytes). In agreement with previousof astrocytes from multipotent neural progenitor cells
derived from the embryonic mammalian SVZ. The BMP- reports (Reynolds and Weiss, 1996), 21.3% of individual
cells (n 5 467 cells) derived from dissociated neuro-mediated astroglial inductive action is associated with
a nearly complete suppression of both neuronal and spheres generated new neurospheres; of these, 82.6%
(n 5 234 spheres) expressed both neuronal lineage– andoligodendroglial lineage elaboration. The multipotent
EGF-generated SVZ progenitor cellsexpress transcripts glial lineage–specific markers after culturing on laminin
substrate for 3 days. When neurospheres were dissoci-encoding the BMP-selective type I and type II serine/
threonine kinase receptor subunits necessary to trans- ated and plated on adherent substrate in the absence
of added factors, the cells were capable of undergoingduce the BMP-mediated developmental signals, as well
Effects of BMPs on SVZ Progenitor Cells
597
Figure 2. BMPs Exhibita Selective Time- and
Dose-Dependent Increase in Astroglial Lin-
eage Species from EGF-Generated SVZ Pro-
genitor Cells
(A) Dose–response analysis of dissociated
cells treated with BMP2 at three factor con-
centrations (5, 25, and 100 ng/ml) and propa-
gated for 1, 2, 4, and 8 days and subsequently
fixed and immunostained for GFAP. Total cel-
lular counts for each experimental condition
were obtained as described in Experimental
Procedures. Each datapoint represents the
mean 6 SEM. Statistical analysis was per-
formed using ANOVA with Bonferroni post
hoc analysis: single asterisk, p < 0.01; double
asterisk, p < 0.001.
(B) Immunocytochemical analysis of cells
treated for 8 days with two different concen-
trations (5 or 50 ng/ml) of members of four
different TGFb subclasses (TGFb, activin, GDNF, and BMP), fixed, immunostained using an antibody against GFAP, and counted. Single
asterisk, p < 0.01; double asterisk, p < 0.001. Only factors from the BMP subclasses showed significant inductive effects; each BMP exhibited
a distinct dose–response profile.
terminal differentiation into neurons, astrocytes, and oli- the dose–response relationships (Figure 2B). The in-
duced astrocytes did not label with the A2B5 mono-godendrocytes, as judged by immunoreactivity of differ-
entiated cells for the earliest recognized lineage-specific clonal antibody, indicating that they are type Iastrocytes
(Cameron and Rakic, 1991). Application of individualantigenic markers (O4, 5.4%; NF66, 79.4%; GFAP,
15.2%; n 5 8 independent wells) and the subsequent BMPs led to an increase in cellular size and process
outgrowth, as well as in GFAP-immunoreactive proteinability to generate phenotypically more advanced post-
mitotic lineage species (as defined by immunoreactivity expression per cell (compare Figures 1A–1D; Figure 3).
In addition, BMP-treated cells were immunoreactive forfor galactocerebroside [galC] and myelin basic protein,
oligodendrocytes; the 200 kDa phosphorylated form of the astrocyte-specific isoform, Yb–GST (Yb subunit of
glutathione S-transferase; Cammer and Zhang, 1992),neurofilament, neurons; GFAP and stellate morphology,
astrocytes). indicating expression of a full complement of astrocytic
properties (data not shown). The BMP inductive effectsApplication of BMPs from two distinct factor sub-
groups, Dpp class (BMP2 and BMP4) and 60A class were not reversible even with very early factor with-
drawal (1–24 hr); cells continued to express the mature(BMP5, BMP6, and OP1/BMP7), resulted in the dramatic
concentration- and time-dependent differentiation of astrocytic phenotype for 6 additional days in culture,
the longest time examined (data not shown).GFAP-immunoreactive astrocytes from dissociated SVZ
progenitor cells (Figures 1A–1D; Figures 2A and 2B). To determine whether BMPs were exerting their ef-
fects on astroglial lineage elaboration by inducing theThis effect was not mimicked by application of factors
from three additional TGFb subclasses (TGFb1, activin proliferation of astroglial lineage species, we examined
the incorporation of bromodeoxyuridine (BrdU), an in-A, and GDNF) (Figure 2B). Furthermore, cotreatment of
progenitor cell cultures with a specific neutralizing anti- dex of cellular proliferation, 1–5 days after the addition
of BMPs and compared this with the accumulation ofbody directed against OP1/BMP7 resulted in complete
suppression of the BMP-mediated elaboration of astro- GFAP-immunoreactive astrocytes. In the presence of
BMP2 (20 ng/ml), the number of astrocytes increasedcytes (Table 1). Although each of theBMPs tested exhib-
ited significant effects, factor differences were noted in in a linear fashion, while the number of mitotically active
cells decreased, indicating that BMPs were not exerting
their actions by increasing the proliferation of astroglial
Table 1. Effects of OP1/BMP7 Neutralizing Antibody on lineage cells (Figures 4A and 4B).
Astroglial Induction
GFAP-IR Cells
BMP Astroglial Inductive Actions Are AssociatedCondition (3 102/cm2)
with the Concurrent Suppression of the
Control 7.6 6 1.3
Oligodendroglial and Neuronal LineagesOP1/BMP7 alone 41.4 6 3.8
To determine whether the effects of the BMPs wereAntibody alone 9.4 6 1.9
limited to astroglial lineage development, we examinedOP1/BMP7 plus antibody 11.6 6 1.2
the effects of BMP2 and representative members ofEGF-generated SVZ progenitor cells (2 3 105) were plated on poly-
three additional TGFb subclasses (TGFb1, activin, andD-lysine-coated coverslips and cultured for 5 days before pro-
GDNF) on the differentiation of EGF-generated SVZ pro-cessing for GFAP-immunoreactive (GFAP-IR) cells. OP1/BMP7 (20
ng/ml) or OP1/BMP7 neutralizingantibodies (Creative Biomolecules; genitor cells into the oligodendroglial and neuronal
1:500) or both were added at the time of plating. The results are the lineages. Double immunofluorescence studies using lin-
mean 6 SEM of triplicate coverslips from a representative experi- eage-specific markers (GFAP, astroglial; neuron-spe-
ment.
cific class III b-tubulin [TuJ1] [Geisert and Frankfurter,
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Figure 3. BMPs Selectively Increase the Ex-
pression of GFAP in Evolving Astroglial Lin-
eage Species Derived from SVZ Progenitor
Cells
SVZ progenitor cells were grown for 8 days
in the presence of two concentrations (5 or
25 ng/ml) of TGFb1 (left), BMP2 (middle), or
OP1/BMP7 (right). GFAP-immunoreactive
protein (50 kDa) was detected by Western
blot analysis using anti-GFAP (1:1000; Sigma)
after SDS–polyacrylamide gel electrophoresis, followed by enhanced chemiluminescence. Each experiment is representative of at least four
independent replications. Potent inductions of GFAP-immunoreactive protein were seen when either equal amounts of protein or equal cell
numbers were loaded. Other BMPs tested were also effective (BMP4, BMP5, and BMP6), whereas additional TGFb superfamily factors were
not (activin and GDNF).
1989], neuronal; galC, oligodendroglial) revealed that, To quantitate more easily the effects of BMPs on oli-
godendroglial lineage elaboration, we optimized the ex-in replicate wells using defined media, BMP2 led to a
marked suppression of neuronal and oligodendroglial pression of oligodendroglial precursors by culturing dis-
sociated EGF-generated SVZ progenitor cells in thelineage elaboration in parallel with an increase in astro-
glial lineage species (Figures 5A–5F). To characterize presence of basic fibroblast growth factor (bFGF) and
platelet-derived growth factor AA (PDGF-AA) for 3 daysmore fully the effects of BMPs on the elaboration of
neuronal lineage species from SVZ progenitor cells, we prior to switching to defined media containing no factors
or BMP2. This condition amplifies the number of oligo-grew cultures in the presence of no additional factors or
with BMP2 or three otherTGFb subclass factors (TGFb1, dendroglial progenitor cells by inducing their prolifera-
tion and preventing differentiation, which is subse-activin, and GDNF) and quantitated the number of neuro-
blasts (NF66-immunoreactive cells) and more advanced quently promoted after medium switching (reviewed by
Barres and Raff, 1994; Pfeiffer et al., 1993). We com-neuronal species (microtubule-associated protein 2
[MAP2]-immunoreactive cells) after 2 and 5 days. Signifi- pared the number of O4- and galC-immunoreactive
(Ranscht monoclonal antibody [RMAb]) cells in culturescantly fewer early and late neuronal lineage cells were
seen in the presence of BMP2 (Figures 6C and 6D) as grown under these conditions with cells exposed to
TGFb superfamily factors. Cultures treated either withcompared with the other conditions, indicating that the
target of the suppressive effects preceded the early no additional factor or with members of three TGFb
superfamily factor subclasses (TGFb1, activin, andneuroblast stage. To ascertain whether selective neu-
ronal cell death contributed to the suppressive effects GDNF) displayed equivalent numbers of progressive oli-
godendroblasts (O4-immunoreactive cells) and early oli-observed in thepresence of BMPs,we evaluatednuclear
staining using Hoechst 33258 in cells labeled with TuJ1, godendrocyte lineage species (RMAb-immunoreactive
cells) (Figures 6A and 6B). By contrast, there was awhich identifies both early and late neuronal cells. At 2
days after the addition of factor, when neuronalsuppres- significant reduction in the numbers of oligodendroglial
lineage cells seen in the presence of BMP2. The de-sion is already apparent, no TuJ1-immunolabeled cells
exhibited nuclear fragmentation, characteristic of apop- crease in both O4- and galC-immunoreactive cells sug-
gests that the target of BMP2 action precedes the O4totic cells (Raff, 1992). Moreover, in the presence of
BMP2, the number of cells expressing neuronal markers oligodendroblast stage. There was no significant de-
crease in oligodendroglial lineage–specific cell numbersdid not decrease between days 2 and 5 (in the absence
of mitogen), as might beexpected if survival of differenti- between days 2 and 5 (in nonproliferative conditions),
suggesting that BMPs had no effect on cellular viabilityating neuronal lineage cells was impaired by factor ad-
dition. of committed oligodendroglial cells (Figures 6A and 6B).
Figure 4. The BMP2 Astroglial Inductive Ef-
fect Is Associated with an Inhibition in Cellular
Proliferation
Dissociated cells were cultured for 1, 2, 3, or
5 days in the presence of BMP2 (20 ng/ml)
or EGF (1 ng/ml; control). BrdU (10 mM) was
added 12 hr prior to fixation, and cells were
then processed for dual immunofluorescence
with antibodies to BrdU (A) and GFAP (B) and
counted. The inductive effect of BMP2 on the
accumulation of astrocytes was associated
with a statistically significant decrease in the
number of mitotically active cells. Cultures
grown in the absence of additional factors
had BrdU incorporation rates similar to those
seen in the presence of BMP2, but few GFAP-
immunoreactive astrocytes were observed
(data not shown). Asterisk, p < 0.001.
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periods of observation (unpublished data). In EGF-gen-
erated SVZ cells, BMPs in fact led to a slight overall
increase in cellular viability, as assayed by MTT staining
when compared with no factor addition (MTT-positive
cells per cm2 with no addition, 3787 6 133; with BMP2,
4655 6 182). Taken together, these observations sug-
gest that BMP treatment of neural progenitor cells sup-
presses neuronal and oligodendroglial lineage elabora-
tion from multipotent progenitor cellsor their early, more
restricted progeny, in parallel with the enhancement of
astroglial lineage elaboration.
SVZ Progenitor Cells Express Transcripts
for the Requisite BMP Receptor Subunits
and for Selected BMP Ligands
The TGFb superfamily factors, including the BMPs, have
been shown to transduce intracellular signals through
selective type I and II receptor subunits that exhibit
different ligand-binding specificities and subunit inter-
actions (Brummel et al., 1994; Estevez et al., 1993; Let-
sou et al., 1995; Kawabata et al., 1995; Penton et al.,
1994). To assess whether the BMP effects on astroglial
lineage elaboration and concurrent oligodendroglial and
neuronal lineage suppression are associated with ex-
pression of the appropriate complement of BMP recep-
tor subunit transcripts, and to assess the expression of
selective BMP ligand transcripts, we performed reverse
transcription–polymerase chain reaction (RT–PCR) on
EGF-generated SVZ neurospheres. We utilized oligonu-
cleotide primers specific for BMP type I (activin-like ki-
nase 3 [ALK3] and ALK6) and type II (BMP-RII) receptor
subunits and for selected BMP ligands (BMP2, BMP4,
and OP1/BMP7). RT–PCR analysis demonstrated the
expression within EGF-generated neurospheres of tran-
scripts for ALK3, ALK6, and BMP-RII and for BMP4 and
OP1/BMP7, but not for BMP2 (Figure 7B). A similar pro-
file was observed in microdissections encompassing
mouse SVZ (data not shown). However, the proportion
and progenitor cell identity of SVZ cells that express the
requisite BMP receptor subunits are not yet known. To
confirm the in vivo expression of BMP transcripts, we
performed quantitative RNase protection assays on stri-
Figure 5. BMPs Selectively Suppress the Elaboration of Oligoden- atal dissections, which included the SVZ, from the brains
droglial and Astroglial Lineage Species from EGF-Generated SVZ
of embryonic, postnatal, and adult mice. The level ofProgenitor Cells
expression of BMP4 transcripts increased between E16Fluorescence photomicrographs of dissociated SVZ progenitor cells
and E18 and then remained stable into adulthood,cultured on laminin-coated coverslips in the absence (A, C, and E)
whereas, as in SVZ-derived cultured progenitor cells,or presence (B, D, and F) of BMP2 (20 ng/ml). Cells were immuno-
stained with antibodies directed against GFAP (A and B), TuJ1 (C the level of BMP2 expression was significantly less (Fig-
and D), or O4 monoclonal antibody (E and F) and developed with ure 7A). These results demonstrate that the relevant
rhodamine- (A, B, E, and F) or fluorescein-conjugated (C and D) BMP ligands and BMP receptors are expressed in brain
secondary antibody. BMP2 led to marked suppression of neuronal at the appropriate developmental times to mediate the
(D) and oligodendroglial (F) lineage species, under conditions that
selective actions of BMPs on the astroglial lineage.concurrently induced the accumulation of astrocytes (B). Cell counts
per cm2 (in the absence or presence, respectively, of BMP2) from
a representative experiment were as follows: astroglial (61 6 3,
299 6 13); neuronal (380 6 12, 45 6 5); oligodendroglial (17 6 1, Discussion
8 6 1). Scale bar is 25 mm in (A)–(D) and 50 mm in (E) and (F).
We have utilized EGF-generated multipotent neural pro-
genitor cells derived from the embryonic murine SVZ to
study the role of TGFb superfamily proteins in neuralMoreover, we did not observe death or detachment of
phase-bright bipolar early oligodendroglial and neuronal lineage commitment. The application of BMPs, which
are members of the DVR subclass (both Dpp and 60Aprecursor cells (which later label with O4 and TuJ1, re-
spectively) in the presence of BMPs during serial 3 hr groups) of this superfamily, but not factors from other
Neuron
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Figure 6. Quantitative Analysis of Neuronal
and Oligodendroglial Lineage Suppression
by BMPs and Other TGFb Superfamily
Factors
Immunocytochemical analysis of cells pre-
treated with bFGF and PDGF-AA (10 ng/ml)
for 3 days to enhance accumulation of oligo-
dendroglial precursor cells (Barres and Raff,
1994; Pfeiffer et al., 1993) and subsequently
propagated after media change for an addi-
tional 2 or 5 days with no added factor or with
BMP2, activin A, TGFb1, or GDNF (10 ng/ml).
Cells were fixed and processed for immuno-
fluorescence and counted using antibodies
that selectively recognize oligodendroblasts
(O4 [A]) or early oligodendrocytes (RMAb [B]).
Parallel cultures grown in the absence of
bFGF and PDGF were stained for markers
expressed in neuroblasts (NF66 [C]) or more
mature neuronal lineage species (MAP2 [D]).
Cells were counted as in Figure 2. Total cellu-
lar counts for each experimental condition
were obtained by counting the entire area of
each coverslip from four independent culture
wells; the results were verified a minimum
of five times. Each datapoint represents the
mean 6 SEM; statistical analysis was per-
formed using ANOVA with Bonferroni post
hoc analysis. Asterisk, p < 0.001.
subclasses (activin, GDNF, and TGFb), led to the dra- was confirmed by the use of BMP-neutralizing antibod-
ies. Moreover, we have found that a proportion ofmatic, concentration-dependent induction of astro-
cytes. This inductive effect was characterized by an multipotent SVZ progenitor cells contain the appropriate
BMP receptor subunit transcripts (type I and II) to en-increase in the commitment and cellular maturation, but
not the proliferation or survival, of astroglial lineage cells code functional BMP receptors, as well as transcripts for
BMP4 and BMP7, but not BMP2. The in vivo relevance ofand the concurrent suppression of neuronal and oligo-
dendroglial lineage species. The specificity of this effect these findings is supported by the demonstration of the
Figure 7. Expression of Transcripts for BMP Type I and II Receptor Subunits and Selected BMP Ligands in EGF-Generated SVZ Progenitor
Cells and the SVZ In Vivo
(A) Quantitative ribonuclease protection assays of BMP2 and BMP4 transcript expression in striatal dissections, including the SVZ, of embryonic,
postnatal (PN), and adult mice. BMP4 expression increased after E16 and then was stable through adulthood, whereas BMP2 expression
remained low throughout the developmental period studied.
(B) RT–PCR agarose gel analysis was performed on EGF-generated SVZ progenitor cells cultured as intact neurospheres without factor
additions prior to RNA extraction. See Experimental Procedures for description of oligonucleotide primers utilized and PCR conditions.
Neurospheres expressed transcripts for BMP type I (ALK3 and ALK6) and type II (BMP-RII) receptor subunits, as well as selected BMP ligands
(BMP4 and OP1/BMP7), but not for BMP2.
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selective expression of transcripts for BMP ligands at transient expression of GFAP immunoreactivity; how-
ever, the effects of the gp130 cytokines alone are onlythe appropriate developmental time and the expression
of BMP receptor transcripts in embryonic SVZ. These temporary, and additional environmental signals are re-
quired for enduring lineage elaboration (Hughes et al.,data support the notion that BMPs function as differen-
tial modulators of glial/neuronal fate decisions in cells 1988; Mayer et al., 1994). Previous studies have indi-
cated that TGFb cytokines, including the BMPs, lead toderived from multipotent and oligopotent SVZ progeni-
tor cells. the transient expression of glial lineage species from
serum-free mouse embryo cells (D’Alessandro and
Wang, 1994; D’Alessandro et al., 1994) and an astrocyteMultipotent SVZ Progenitor Cells as a Model
progenitor cell line (Sakai et al., 1990; Yoshida and Tak-System for the Study of Glial/Neuronal
euchi, 1993; Yoshida et al., 1993). In contrast, we haveFate Determination
demonstrated irreversible astroglial lineage elaborationThe multipotent progenitor cells of the SVZ provide an
and enhanced expression of astroglial-specific proteinsimportant model system with which to study the effects
in cells derived from SVZ progenitor cells in the presenceof epigenetic and genetic signals on glial/neuronal fate
of BMPs. Premature withdrawal of BMPs in culturesdecisions. Cultured intact SVZ-derived neurospheres,
propagated for prolonged periods did not alter the num-and dissociated cells shortly after plating on adherent
ber of astrocytes observed, nor the expression ofsubstrates, were shown to express lineage-independent
astrocytic properties. Thus, the survival of astrocytesand early neuroepithelial antigenic markers, but not lin-
generated in the presence of BMPs did not require theeage-specific markers, consistent with their identifica-
continuous de novo activation of a differentiation signal-tion as undifferentiated neural stem/progenitor cells
ing cascade. Although BMP treatment slightly increased(Frederiksen et al., 1988; Frederiksen and McKay, 1988).
the number of MTT-positive viable cells, the effect wasAfter plating on adherent substrates, these cells differ-
not large enough to account for the 6-fold increase inentiated into each of the three major CNS neuroepithelial
the production of astroglial lineage cells. The expressionlineages. Recent studies support the existence of pro-
of GFAP in some untreated cells, albeit at very low levels,genitor cells from various mammalian brain regions that
raises the possibility that some of the observed actionsgenerate neuronal and glial cells in vivo and in vitro
of the BMPs reflected increased expression of astro-(Gates et al., 1995; Kilpatrick and Bartlett, 1993; Lois
cyte-specific gene products in nascent astroglial lin-and Alvarez-Buylla, 1993; Reynolds et al., 1992; Reyn-
eage–committed cells. However, we have observed thatolds and Weiss, 1992; Temple, 1989; Turner and Cepko,
morphological changes occur very early after BMP addi-1987; Williams and Price, 1995). Additional experiments
tion (within 12 hr), well before evidence of increasedhave also demonstrated that individual EGF-generated
GFAP expression. Thus, the marked changes in cell sizeSVZ progenitor cells, cortical progenitor cells, and con-
and process outgrowth are not likely to be simply theditionally immortalized CNS neural stem/progenitor
result of increased glial filament accumulation, butcells can give rise to clones containing each of the three
rather reflect more profound effects of BMPs on astro-neuroepithelial lineages in vitro (Davis and Temple, 1994;
glial lineage elaboration.Mehler et al., 1995, Soc. Neurosci., abstract; Nakafuku
BMPs might be acting to increase proliferation of mi-and Nakamura, 1995; Reynolds and Weiss, 1996; Wil-
totically active cellular precursors of astrocytes. How-liams and Price, 1995). EGF-responsive SVZ precursor
ever, following BMP application, only a small proportioncells have also been demonstrated in vivo in the mouse
(10.2 6 1.4%, n 5 8 wells) of SVZ progenitor cell–derivedbrain, where EGF stimulation leads to the proliferation,
GFAP-immunoreactive cells were mitotically active.survival, and migration of progenitor cells that ultimately
These observations demonstrate that the BMP inductivedifferentiate into neurons, astrocytes, and oligodendro-
effects are not a result of selective proliferation of com-cytes (Craig et al., 1996). Thus, this in vitro model system
mitted astroglial lineage cells. It remains possible, how-reflects the potential cell fates that are acquired in vivo
ever, that BMPs are inducing the differentiation of aand provides a convenient assay system for potential
population of committed astroglial precursors thatregulators of neural cell fate determination.
would otherwise, in defined medium, fail to express as-
troglial-specific markers and cellular morphologies. In
The Role of BMPs in Glial/Neuronal Fate this scenario, it would not be predicted, a priori, that
Decisions by SVZ Progenitor Cells BMPs would affect the development of alternate SVZ
While a number of neurotrophic factors and cytokines progenitor lineages. In fact, the induction of astrocytes
have been implicated in the differentiation and cellular might be expected to foster the survival of oligodendro-
maturation of glia and neurons in vitro and in vivo, the glial cells (Lillien and Raff, 1990), and BMPs have been
role of epigenetic signals in glial/neuronal lineage com- shown to promote the expression of a differentiated
mitment in the mammalian CNS is presently unknown. In neuronal phenotype (Lein et al., 1995). On the contrary,
the rat optic nerve, bipotent oligodendroglial–astroglial in addition to programming the enduring expression of
progenitors have been identified and utilized in an in astrocytes, the BMPs exhibited concurrent suppression
vitro model system to examine signals that regulate neu- of the oligodendroglial and neuronal lineages. These
ral lineage decisions (Lillien and Raff, 1990; Raff et al., alternate CNS lineages normally exhibit robust patterns
1983). Within this experimental system, gp130 subclass of expression in cultures of SVZ progenitor cells in the
cytokines that utilize the leukemia inhibitory factor re- absence of BMPs. The absence of neuronal and oligo-
dendroglial lineage species following BMP applicationceptor b signaling subunit preferentially program the
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was not the result of an adverse effect on the survival the peripheral nervous system (Stemple and Anderson,
1992; reviewed by Anderson, 1995). Shah et al. (1994)of these alternate lineages: nuclear fragmentation of
lineage-specific cells and cellular debris were not ob- and Dong et al. (1995) have shown that glial growth
factor (GGF) (Neu differentiation factor), a member ofserved at early timepoints or after serialbrief (3 hr) obser-
vation periods, and overall viability was slightly in- the EGF/TGFa family of factors secreted by neural crest
cell–derived oligopotent progenitor species, influencescreased after the addition of BMPs to SVZ cell cultures.
Moreover, the number of cells expressing early lineage- the acquisition of a glial (Schwann cell) fate and the
suppression of a neuronal fate. Based on the results ofrestricted markers (e.g., NF66 and O4) did not decrease
with time after BMP addition in nonproliferative condi- in vitro clonal analysis, this glial/neuronal fate decision
appears to be the result of an instructive action of GGFtions. It is possible that neuronal and oligodendroglial
lineage precursors could have detached from the sub- on the neural crest cell lineage (Shah et al., 1994). This
instructive effect in the peripheral nervous system isstrate prior to the expression of lineage-restricted mark-
ers. However, detachment of immature cell types was analogous to ourcurrent observations using mammalian
CNS-derived progenitor cells; a comparable action ofnot observed within developing SVZ progenitor cells
during serial short observation periods at clonal density. GGF on lineage elaboration by SVZ progenitor cells was
not observed (unpublished data). BMPs and activin haveTaken together, these results support the hypothesis
that the BMPs act to induce the commitment of multipo- been shown to influence the differentiation of neural
crest cell–derived neurons (Fann and Patterson, 1994;tent SVZ progenitors, or theirmore restricted progeny, to
the glial lineage with concurrentsuppression of alternate Lein et al., 1995). Recently, Shah et al. (1996) have dem-
onstrated that BMP2 and TGFb1 are instructive for neu-lineage commitment.
Clonally derived SVZ progenitor cells are truly multipo- ral crest stem cells, influencing the elaboration of the
neuronal and smooth muscle lineages, respectively.tent, giving rise to each of the three major CNS lineages
under differentiating conditions (Reynolds and Weiss, While the particular cell fates dictated by the BMPs may
vary depending on the nature of the target multipotent1996). However, more restricted, oligopotent progeni-
tors have been demonstrated both in SVZ cultures and cell, the instructive actions of the BMPs on lineage elab-
oration are similar to those described here.in vivo (Davis and Temple, 1994; Kilpatrick and Bartlett,
1993; Levison and Goldman, 1993; Lois and Alvarez-
Buylla, 1993; Raff et al., 1983; Skoff, 1990; Temple, 1989; Expression of Transcripts for BMP Receptor
Subunits and BMP Ligands in SVZWilliams et al., 1991; Williams and Price, 1995; Vescovi
et al., 1993). We have demonstrated that the targets of Progenitor Cells
BMPs mediate their effects on intracellular processesthe actions of BMPs are cells that have not yet begun
to express differentiated markers. In the absence of through serine/threonine kinase receptors, comprised
of type I (ALK3 and ALK6) and type II (BMP-RII) subunitsknown early markers for committed SVZ-derived precur-
sor cells that do not yet express lineage-specific proper- (Brummel et al., 1994; Estevez et al., 1993; Kawabata et
al., 1995; Letsou et al., 1995; Penton et al.,1994). Optimalties, it is not yet possible to ascertain definitively the
degree of lineage commitment of these cellular targets. BMP signal transduction requires the cooperation of
both type I and type II receptor subunits (Liu et al., 1995).We have noted, however, that in conditions in which
proliferative stem/progenitor cells cannot differentiate We have shown that undifferentiated SVZ progenitor
cells (derived from intact neurospheres) encode tran-(in the absence of substrate), BMPs markedly reduce
cellular proliferation. Thus, two alternate explanations scripts for ALK3, ALK6, and BMP-RII. Thus, the neces-
sary cellular signaling apparatus exists at the appro-for our observations are possible. In the first, BMPs act
independently and differentially on each of the commit- priate developmental stage to transduce the effects of
the BMPs. The expression of selected BMP ligandsted yet undifferentiated precursors of the three cell types
derived from SVZ progenitor cells, as well as on prolifer- within a subpopulation of SVZ progenitor cells suggests
the presence of complex autocrine or paracrine signal-ative stem/multipotent cells. In the second, more parsi-
monious model, BMPs act in a unitary manner on ing interactions (or both). During gastrulation, activins or
activin-like molecules are secreted by dorsal mesodermmultipotent cells, facilitating cell cycle exit and commit-
ment to the astroglial lineage at the expense of alternate and diffuse to influence tissue morphogenesis at vari-
able distances from the source (Jones et al., 1991; re-cell fates. These observations would thus define a puta-
tive glial/neuronal regulatory pathway within the CNS viewed by Green, 1994; Jessell and Melton, 1992). The
target tissues contain no detectable BMPs. However,and provide evidence that lineage determination along
this pathway can be controlled by a limited repertoire during neural plate induction, BMP4 and BMP7 ex-
pressed in epidermal ectoderm act over short distancesof epigenetic signals. In addition, within the developing
brain, EGF and similar early-acting factors may “prime” and require cell–cell contact to induce the generation
of dorsal cell fates from neural progenitors in the neuralSVZ progenitor cells to be responsive to these specific
instructive signals that are necessary for selective lin- plate (Liem et al., 1995). Moreover, BMP4 and the related
gene, dorsalin 1, are subsequently expressed in the dor-eage elaboration. Further, BMPs may exhibit a comple-
mentary spectrum of context-dependent developmental sal neural tube itself. Hence, in situations inwhich induc-
tive effects are mediated by factors that act via cell–cellactions on alternate lineages in the CNS, including po-
tentiation of survival and cellular maturation (Mehler and contact, by diffusion over short distances, or in an auto-
crine fashion, the effector and its target can be ex-Kessler, 1994).
The epigenetic control of glial/neuronal fate decisions pressed in the same tissue. Thus, we propose that se-
lected BMPs are expressed by SVZ cells and exert theirin multipotent progenitor cells has been examined in
Effects of BMPs on SVZ Progenitor Cells
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immunoglobulin G1 [mIgG1], 1:400; Sigma); nestin (supplied by R.actions locally, either by concentration-dependent ef-
McKay, National Institute of Neurological Disorders and Stroke, Na-fects or by focal sequestration within the extracellular
tional Institutes of Health; rabbit [r] Ig, 1:400); O4 (supplied by S.matrix. These developmental actions can thus allow the
Pfeiffer, University of Connecticut; mIgM, 1:1); RMAb (supplied by
establishment of concurrent positive and negative lin- S. Pfeiffer; mIgG3, 1:1); NF66 (supplied by A. Chiu, Albert Einstein
eage regulatory actions coded by spatial integration (Ar- College of Medicine; rIg, 1:100); MAP2 (supplied by P. Davies, Albert
Einstein College of Medicine; mIgG, 1:500); TuJ1 (supplied by A.tavanis-Tsakonas et al., 1995; Heitzler et al., 1996; Simp-
Frankfurter, University of Virginia; mIgG2a, 1:1000). Following wash-son, 1995). In vivo, we envision that spatial and temporal
ing in PBS for 10 min at room temperature, secondary antisera werefactors, or even the developmentally regulated expres-
applied, alone or in combination. The appropriate isotype-specificsion of BMP antagonists (e.g., follistatin or chordin), lead
secondary antisera were either rhodamine-conjugated, fluores-
to the alternate generation of nonastroglial lineages at cein-conjugated (Southern Biotechnologies; 1:100), or Cascade
the appropriate developmental times. BMPs may thus blue–conjugated (Molecular Probes; 1:100). Some coverslips were
counterstained with Hoechst 33258 (Sigma) to visualize nuclear frag-represent one of a series of epigenetic signals that regu-
mentation. After final washing, coverslips were mounted in anti-fadelate the integrated expression of sequential CNS lin-
reagent (Vectashield, Vector Laboratories), and photographed usingeages.
an Olympus BX50 fluorescence microscope. Total cellular counts
for each experimental condition were obtained by examining the
Experimental Procedures entire area of each coverslip from four independent culture wells;
the results of each experimental condition were verified a minimum
of five times.Culture of EGF-Generated SVZ Progenitor Cells
Striata from E17 CD1 mouse embryos (Taconic) were removed and
processed for the establishment of EGF-generated neurospheres Treatment of SVZ Progenitor Cells with OP1/BMP7
Neutralizing Antibodywith the following modifications from previous descriptions (Reyn-
olds et al., 1992; Vescovi et al., 1993). Cells (5 3 104 per milliliter) Multiply passaged neurospheres were cultured as above, dissoci-
ated, and plated at 1 3 105 cells per well in laminin-coated 24-wellwere seeded into 75 cm2 uncoated culture flasks in serum-free me-
dium (SFM), consisting of DMEM/F12 with nutrient additives as de- multiwell plates. Triplicate wells were cultured for an additional 5
days with and without OP1/BMP7 (20 ng/ml) in the presence orscribed by Reynolds et al. (1992), in the presence of EGF (10 ng/
ml) and cultured for 7 days to generate proliferative neurospheres absence of OP1/BMP7 neutralizing antibody (mouse monoclonal
IgG, 1:500 dilution; provided by Creative Biomolecules). Cells wereat the stage of maximal size and viability. To prevent the propagation
of nonproliferative populations, cellular preparations were passaged then fixed with methanol and immunostained using GFAP antisera
as above, except that immunoperoxidase-conjugated secondary3–4 times by mechanical dissociation of suspended neurospheres,
followed by reseeding at the above density to regenerate prolifera- antibody (Vector Laboratories) was used as per recommendations of
the manufacturer. Cells were counted under bright-field illuminationtive neurospheres. To determine the proportion of individual dissoci-
ated EGF-derived cells that are capable of reforming neurospheres, using a Nikon Diaphot microscope.
we titered passaged cells to yield 100 viable cells per cm2 (trypan
blue exclusion method). These cells were plated in 24-well multiwell Western Blot Analysis
culture plates (Falcon) without substrate in SFM and treated at the Dissociated cells were plated in 6-well multiwell plates coated with
time of plating with EGF (10 ng/ml), and the number of neurospheres laminin (Collaborative Biomedical Products) at 1 3 105 cells per well
per well was serially quantitated for 7 days. To assess further the and cultured for 8 days in the presence of no factor or TGFb1,
proportion of these clonally derived progenitor populations that ex- BMP2, or OP1/BMP7 (5 and 25 ng/ml). Cellular preparations were
press both neuronal and glial markers, we plated individual neu- harvested in buffer solution containing 1.0%SDS and 5% b-mercap-
rospheres on laminin substrate (20 mg/ml; Collaborative Biomedical toethanol and processed as previously described (Cammer and
Products) in SFM without additional factors for 3 days and subse- Zhang, 1992). Samples (20 mg of protein) were loaded onto poly-
quently fixed and processed them for dual immunofluorescence acrylamide gels (13%), which were thereafter transferred to nitrocel-
microscopy using TuJ1 (neuronal) and GFAP (glial) lineage markers. lulose filters and blocked with 5% nonfat milk for 1 hr. After incuba-
Dissociated neurospheres were plated on poly-D-lysine (20 ng/ tion with anti-GFAP monoclonal antibody (Sigma), specific bands
ml) or laminin (5 mg/cm2; CollaborativeBiomedical Products)-coated (50 kDa) were detected with enhanced chemiluminescence.
12 mmcoverslips (5 3 104 cells;Assistent) in 24-wellmultiwell culture
plates (Falcon) and propagated in the presence or absence of vari- MTT Cell Viability Assay
ous TGFb superfamily factors at the concentrations noted in the At 24 hr after no factor addition or the addition of BMP2 (20 ng/ml),
figure legends. Some cultures contained bFGF (10 ng/ml) or PDGF- cultures were incubated with MTT (3[4,5-dimethylthiazol-2-yl]-2,5-
AA (10 ng/ml) or both, as noted, to facilitate survival of differentiated diphenyl tetrazolium bromide; Sigma) at a final concentration of 100
lineages. The factors used were as follows: recombinant human mg/ml for 1 hr at 378C and quantitated by light microscopy, as
BMP2, BMP4, BMP5, and BMP6 (supplied by Genetics Institute, previously described (Mehler et al., 1995).
Cambridge, MA); recombinant human OP1/BMP7 (supplied by Cre-
ative Biomolecules, Hopkinton, MA); recombinant murine TGFb1 BrdU Incorporation Assay
(supplied by Bristol–Meyers–Squibb); recombinant activin (supplied EGF-generated SVZ progenitor cells were cultured as above in the
by Genentech); recombinant human GDNF (purchased from Pro- presence or absence of BMP2 (20 ng/ml) or EGF (1 ng/ml) for 1, 2,
mega); and purified murine EGF, bFGF, and PDGF-AA (purchased 3, and 5 days. Cells were pulsed with BrdU (10 mm; Sigma) for 12
from Collaborative Biomedical Products). hr prior to fixation and processing for dual-labeled immunocyto-
chemical analysis, using anti-GFAP (Sigma) and anti-BrdU antisera
(Boehringer-Mannheim; following the recommendations of the man-Immunocytochemistry for Qualitative
ufacturer), followed by isotype-specific fluorochrome-conjugatedand Quantitative Analyses
secondary antisera. Cellular counts were performed as above.After various times, coverslips were fixed with ice-cold methanol
and processed for indirect immunofluorescence microscopy. Fixed
coverslips were washed in phosphate-buffered saline (PBS) then RNase Protection Assay
Total cellular RNA was prepared from striatal microdissections,preincubated for 30 min in the appropriate blocking serum (goat or
horse) followed by overnight incubation in primary antisera at 48C which included the SVZ, from CD1 mice (Taconic) ranging in age
from E16 to adult using guanidinium thiocyanate–phenol–chlo-with gentle agitation. For O4 and RMAb staining, live cells were
washed once with PBS, followed by incubation for 30 min at 48C in roform (Sigma) according to the recommendations of the manufac-
turer. RNA (10 mg) was subjected to nuclease protection assays,undiluted antisera. Cells were then washed once with PBS and
fixed as above. The following antisera were used: GFAP (mouse using 32P-labeled cRNAs transcribedfrom vectors containing murine
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BMP2 and BMP4 cDNAs (provided by Genetics Institute) as pre- Cammer, W., and Zhang, H. (1992). Localization of m class glutathi-
one-S-transferase in the forebrains of neonatal and young rats: im-viously described (Mehler et al., 1995). cRNA standard curves were
constructed for quantitation, and levels of b-actin transcripts were plications for astrocyte development. J. Comp. Neurol. 321, 33–39.
used for standardization. Densities of the signal bands were quanti- Cattaneo, E., and McKay, R. (1990). Proliferation and differentiation
fied by a computing densitometer (Molecular Dynamics), and con- of neuronal stem cells regulated by nerve growth factor. Nature 347,
verted to picograms per microgram of total RNA. The results re- 762–765.
ported (6 SEM) are from triplicate specimens of a representative
Craig, C.G., Tropepe, V., Morshead, C.M., Reynolds, B.A., Weiss,experiment.
S., and van der Kooy, D. (1996). In vivo growth factor expansion of
endogenous subependymal neural precursor cell populations in theRT–PCR Analysis of SVZ Progenitor Cells
adult mouse brain. J. Neurosci. 16, 2649–2658.RNA was isolated from EGF-generated SVZ neurospheres estab-
D’Alessandro, J.S., and Wang, E.A. (1994). Bone morphogeneticlished as described above. RT–PCR was performed using the hot
proteins inhibit proliferation, induce reversible differentiation andstart technique as previously described (Mehler et al., 1995). The
prevent cell death in astrocyte lineage cells. Growth Factors 11,samples underwent PCR (40 cycles) consisting of the following
45–52.steps: denaturation at 948C for 1 min; annealing at 608C for 1 min;
and extension at 728C for 2 min. Oligonucleotide primers were de- D’Alessandro, J.S., Yetz-Aldape, J., and Wang, E.A. (1994). Bone
signed for murine ALK3 (59 sense primer, 59-CAGACTTGGACCAG morphogenetic proteins induce differentiation in astrocyte lineage
AAGAAGCC-39; 39 antisense primer, 59-ACATTCTATTGTCTGCGT cells. Growth Factors 11, 53–69.
AGC-39), murine ALK6 (59 sense primer, 59-AAGAAGATGACTCTGG Davis, A.A., and Temple, S. (1994). A self-renewing multipotential
AATGAA-39; 39 antisense primer, 59-ATCCACACCTCGCCATA stem cell in embryonic rat cerebral cortex. Nature 372, 263–266.
GCG-39), murine BMP-RII (59 sense primer, 59-GCTTCGCAGAATCA
Dewulf, N., Verschueren, K., Lonnoy, O., More´n, A., Grimsby, S.,AGAACG-39; 39 antisense primer, 59-GTGGACTGAGTGGTGTT
Vande Spiegle, K., Miyazono, K., Huylebroeck, D., and Ten Dijke,GTG-39), rat BMP2 (59 sense primer, 59-CCAGGTTAGTGACTCAG
P. (1995). Distinct spatial and temporal expression patterns of twoAACAC-39; 39 antisense primer, 59-TCATCTTGGTGCAAAGACC
type I receptors for bone morphogenetic proteins during mouseTGC-39), murine BMP4 (59 sense primer, 59-TAGCAAGAGTGCCG
embryogenesis. Endocrinology 136, 2652–2663.TCATTCC-39; 39 antisense primer, 59-CCAGTCTCGTGTCCAGTAG
Dong, Z., Brennan, A., Liu, N., Yarden, Y., Lefkowitz, G., Mirsky, R.,TCG-39), and murine OP1 (59 sense primer, 59-CGATTTCAGCCTGGA
and Jessen, K.R. (1995). Neu differentiation factor is a neuron–gliaCAACG-39; 39 antisense primer, 59-CCTGGGTACTGAACACGG-39).
signal and regulates survival, proliferation, and maturation of rat
Schwann cell precursors. Neuron 15, 585–596.Acknowledgments
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